The Value Analysis Committee. Three words that can make even a seasoned medical device rep's stomach drop. You've done the legwork. The surgeon is on board. The clinical staff loves it. And then someone says, "We'll need to run this through the VAC."
For some reps, that's where the deal stalls indefinitely. For others, it's just the next step in the process. The difference is preparation.
What the VAC Actually Cares About
Understanding the committee's priorities is the first step to winning their approval. A VAC isn't trying to kill your deal — they're trying to protect the hospital. Their job is to evaluate new products against three core criteria:
Clinical value. Does this product deliver meaningfully better outcomes than what we already have? Not just "it's new" — but specifically better, and provably so.
Financial impact. What does it cost, and what does it save? VAC members — especially the CFO and supply chain leads — are running numbers. If you don't provide those numbers, they'll fill in the blanks themselves, and not in your favor.
Implementation risk. How disruptive will this be to introduce? Do we need to retrain staff? What's the transition timeline? The committee wants to know you've thought through the rollout, not just the sale.
The Biggest Mistake Reps Make With the VAC
Showing up with a product brochure and a smile.
The VAC has seen a thousand reps walk through that door. What they haven't seen enough of is a rep who comes prepared with a clinical evidence summary, a cost comparison, a proposed pilot design, and answers to the questions they haven't asked yet.
That level of preparation signals something important: you're not just here to close a deal. You're here to be a partner.
Build Your Champion Before the Meeting
The VAC decision rarely happens in the room. It's made in the conversations that lead up to the meeting — between the physician champion and their colleagues, between the nurse manager and the CNO, between supply chain and finance.
Your job before the VAC meeting is to equip your champion with everything they need to advocate internally. That means giving them language for the clinical argument, data for the financial case, and answers to the objections they'll face in the hallway.
AI is remarkably good at helping you draft exactly that kind of supporting material — tailored to each stakeholder's perspective.
Design a Pilot That Removes Risk
One of the most effective VAC strategies is coming in with a pilot proposal already designed. Instead of asking for a full formulary approval, ask for a 90-day pilot with defined success metrics. This dramatically lowers the perceived risk of a "yes."
A well-designed pilot proposal includes: the clinical question you're trying to answer, the metrics you'll track, the timeline, and the criteria for full adoption. With AI, you can build this document in under an hour — and it will look like it took a week.
What Happens After the Approval
Winning the VAC is the beginning, not the end. The reps who build lasting account penetration are the ones who follow through — delivering on every promise made in that meeting, tracking the metrics they committed to, and making the committee look smart for saying yes.
That follow-through is what turns a single approval into a long-term partnership — and into competitive insulation that's very hard for a rival rep to undo.